CLINICAL_TRIALS
trial_result
· 2019-08-20
Clinical Trial Update: TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation [NA]
Summary
A completed clinical trial update for TactiSense IDE trial of TactiCath SE in paroxysmal atrial fibrillation with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2019-08-20